Stay updated on Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a revision note 'Revision: v3.3.3'. Removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.2%
    Check dated 2025-12-23T14:20:43.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown in the page footer, replacing v3.3.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:26:42.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page history shows a new 'Revision: v3.3.1' entry added and the previous 'Revision: v3.2.0' entry removed, reflecting a minor maintenance update to revision labeling and not altering listed study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:37:23.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Removed the government funding and operating status banner from the top of the page. The rest of the study record content remains unchanged.
    Difference
    0.6%
    Check dated 2025-11-17T06:56:10.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The new version adds a termination notice for the study, noting that AstraZeneca stopped enrollment and Part 2 was not initiated. It also updates the study status and enrollment details.
    Difference
    0.1%
    Check dated 2025-11-03T01:22:15.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    11%
    Check dated 2025-10-05T10:21:33.000Z thumbnail image

Stay in the know with updates to Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.